Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia

Schizophrenia Research

Volumn 137, Issue 1-3, 2012, Pages 246-250

  Wallwork, R S ^a   Fortgang, R ^a   Hashimoto, R ^b,d   Weinberger, D R ^a,c   Dickinson, D ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cognition; PANSS; Schizophrenia; Symptoms

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; COGNITION; CONSENSUS; DEPRESSION; DISORIENTATION; EXCITEMENT; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; JAPANESE; MAJOR CLINICAL STUDY; MALE; MODEL; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; SYMPTOM;

ADULT; COGNITION DISORDERS; CONSENSUS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84860839624     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.01.031     Document Type: Article

References (42)

1. Abdel-Hamid M., Lehmkämper C., Sonntag C., Juckel G., Daum I., Brüne M. Theory of mind in schizophrenia: The role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions. Psychiatr. Res. 2009, 165(1-2):19-26.
2. American Psychiatric Association DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders. Text Revision 2000, American Psychiatric Association, Washington, DC. fourth ed.
3. Bell M.D., Lysaker P.H., Beam-Goulet J.L., Milstein R.M., Lindenmayer J.P. Five-component model of schizophrenia: assessing the factorial invariance of the Positive and Negative Syndrome Scale. Psychiatry Res. 1994, 52(3):295-303.
4. Blanchard J.J., Kring A.M., Horan W.P., Gur R. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr. Bull. 2011, 37(2):291-299.
5. Bunk D., Eggers C., Klapaln M. Symptom dimensions in the course of child-onset schizophrenia. Eur. Child Adolesc. Psychiatry 1999, 8(Supplement 1):I/29-I/35.
6. Citrome L., Meng X., Hochfeld M. Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis. Schizophr. Res. 2011, 131(1-3):75-81.
7. Cohen A.S., Alpert M., Nienow T.M., Dinzeo T.J., Docherty N.M. Computerized measurement of negative symptoms in schizophrenia. J. Psychiatr. Res. 2008, 42(10):827-836.
8. Dickinson D., Goldberg T.E., Gold J.M., Elvevåg B., Weinberger D.R. Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophr. Bull. 2011, 37(6):1157-1167.
9. Dollfus S., Petit M. Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase. Eur. Psychiatry 1995, 10(2):97-106.
10. Drake R.J., Dunn G., Tarrier N., Haddock G., Haley C., Lewis S. The evolution of symptoms in the early course of non-affective psychosis. Schizophr. Res. 2003, 63(1-2):171-179.
11. Dudek, P.T., 2005. An Examination of the Factor Structure of the SCI-PANSS. Unpublished manuscript, Philadelphia.
12. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Rawlings R., Hyde T.M., Bigelow L., Weinberger D.R. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol. Psychiatry 2001, 50(2):98-107.
13. Emsley R., Rabinowitz J., Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr. Res. 2003, 61(1):47-57.
14. Flora D.F., Curran P.J. An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol. Methods 2004, 9(4):466-491.
15. Fredrikson D., Steiger J., MacEwan G., Altman S., Kopala L., Flyn S., Liddle P., Honer W. PANSS symptom factors in schizophrenia. Schizophr. Res. 1997, 24(1-2):15-16.
16. Fresán A., De la Fuente-Sandoval C., Loyzaga C., García-Anaya M., Meyenberg N., Nicolini H., Apiquian R. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenia patients. Schizophr. Res. 2005, 72(2-3):123-129.
17. Higashima M., Urata K., Kawasaki Y., Maeda Y., Sakai N., Mizukoshi C., Nagasawa T., Kamiya T., Yamaguchi N., Koshino Y. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biol. Psychiatry 1998, 44(2):115-120.
18. Kay S.R., Sevy S. Pyramidical model of schizophrenia. Schizophr. Bull. 1990, 16(3):537-545.
19. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
20. Kline R.B. Principles and Practice of Structural Equation Modeling 2010, Guilford, New York.
21. Lançon C., Auquier P., Nayt G., Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr. Res. 2000, 42(3):231-239.
22. Lee K.-H., Harris A.W., Loughland C.M., Williams L.M. The Five Symptom Dimensions and Depression in Schizophrenia. Psychopathology 2003, 36(5):226-233.
23. Lehoux C., Gobeil M.H., Lefebvre A.A., Maziade M., Roy M.A. The Five-Factor Structure of the PANSS: A Critical Review of its Consistency Across Studies. Clin. Schizophr. Relat. Psychoses 2009, 3(2):103-110.
24. Lépine J.P. Dimensions positives et négatives dans les schizophrénies. Les Cahiers de Prisme 1991, 1:23-29.
25. Levine S.Z., Rabinowitz J. Revisiting the 5 Dimensions of the Positive and Negative Syndrome Scale. J. Clin. Psychopharmacol. 2007, 27(5):431-436.
26. Lindenmayer J.-P., Bernstein-Hyman R., Grochowski S., Bark N. Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology 1995, 28(1):22-31.
27. Lindenmayer J.-P., Grochowski S., Hyman R.B. Five factor model of schizophrenia: replication across samples. Schizophr. Res. 1995, 14(3):229-234.
28. Lindstrom E., von Knorring L. Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for schizophrenia. Nord. J. Psychiatry 1993, 47(4):257-263.
29. Llorca P.M., Blanc O., Samalin L., Bosia M., Cavallaro R., on behalf of the EGOFORS initiative Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling. Eur. Psychiatry 2011, Available online 30 June 2011, ISSN 0924-9338, 10.1016/j.eurpsy.2011.01.010.
30. Lykouras L., Oulis P., Psarros K., Daskalopoulou E., Botsis A., Christodoulou V.N., Stefanis C. Five-factor model of schizophrenic psychopathology: how valid is it?. Eur. Arch. Psychiatry Clin. Neurosci. 2000, 250(2):93-100.
31. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. J. Clin. Psychiatry 1997, 58(12):538-546.
32. Mass R., Schoemig T., Hitschfeld K., Wall E., Haasen C. Psychopathological Syndromes of Schizophrenia: Evaluation of the Dimensional Structure of the Positive and Negative Syndrome Scale. Schizophr. Bull. 2000, 26(1):167-177.
33. Monteiro L.C., Silva V.A., Louza M.R. Insight, cognitive dysfunction and symptomatology in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2008, 258(7):402-405.
34. Muthén L.K., Muthén B. Mplus user's guide, version 4 1998-2007, Muthén & Muthén, Los Angeles.
35. Ohi K., Hashimoto R., Yasuda Y., Fukumoto M., Yamamori H., Umeda-Yano S., Kamino K., Ikezawa K., Azechi M., Iwase M., Kazui H., Kasai K., Takeda M. The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(5):1309-1315.
36. Serretti A., Olgiati P. Dimensions of major psychoses: a confirmatory factor analysis of six competing models. Psychiatry Res. 2004, 127(1-2):101-109.
37. Van den Oord E.J.C.G., Rujescu D., Robles J.R., Giegling I., Birrell C., Bukszár J., Murrelle L., Möller H.J., Middleton L., Muglia P. Factor structure and external validity of the PANSS revisited. Schizophr. Res. 2006, 82(213-223).
38. van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale I: Confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr. Res. 2006, 85(1-3):273-279.
39. van der Gaag M., Hoffman T., Remijsen M., Jihman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Cuijpers A., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model. Schizophr. Res. 2006, 85(1-3):280-287.
40. von Knorring L., Lindstrom E. Principal components and further possibilities with the PANSS. Acta Psychiatr. Scand. 1995, 91(suppl 388):5-10.
41. White I., Harvey P.D., Opler L., Lindenmayer J.P., Group t.P.S. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopharmacology 1997, 30(5):263-274.
42. Wolthaus J.E., Dingemans P.M., Schene A.H., Linszen D.H., Knegtering H., Holthausen E.A., Cahn W., Haijman R. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology (Berl) 2000, 150(4):399-403.